Event Highlights – May 13, 2025
The Anglonordic Life Science Conference concluded its 21st edition at London’s historic County Hall on April 3rd, 2025. With over 350 registered delegates, the event celebrated over two decades of driving innovation and deepening collaboration across the UK, Nordic region, and Europe. More than ever before, this year showcased the power of cross-border partnerships and set the tone for an even more impactful future in the life sciences.
Pharma Business – May 12, 2025
The US Food and Drug Administration (FDA) has approved Aqilion’s IND (investigational new drug) application for the drug candidate AQ280.
Global report – May 12, 2025
The policy prevents the NSF from awarding new research grants and from supplying allotted funds for existing grants, such as those that receive yearly increments of money.
Biotech Business – May 12, 2025
The company has announced the successful completion of the manufacture of the first GMP drug product batch of its lead asset mitazalimab using a new improved commercial-scale manufacturing process.
Intellectual Property – May 12, 2025
The US Patent and Trademark Office (USPTO) has granted Prolight a patent for the analytical unit and reaction chamber for the company’s point-of-care analysis system, MicroFlex, which is being developed by Prolight’s partner TTP (The Technology Partnership).
Biotech Business – May 8, 2025
Alvotech has announced that it intends to list Swedish Depository Receipts (SDRs), equity share equivalents, on Nasdaq Stockholm.
Clinical Trials – April 13, 2025
The companies have announced positive in-vivo proof-of-concept data for a powder-based intranasal vaccine candidate formulated with the AmorphOX technology. The data was generated under the collaboration between Orexo and Abera Biosciences entered in December 2024. The aim of the collaboration is to develop mucosal vaccines by combining Orexo’s powder-based drug delivery technology AmorphOX with Abera’s […]
Clinical Trials – April 9, 2025
A new clinical trial map is now accessible from the public website of the Clinical Trials Information System (CTIS).
Clinical Trials – March 25, 2025
Immunovia has announced additional results from the VERIFI study of its next-generation pancreatic cancer test, strengthening the company’s position as it prepares to launch the pancreatic cancer blood test commercially.
Clinical Trials – March 18, 2025
The FDA has approved the company’s IND application to initiate the Phase I/II study Oncorella-1.
Clinical Trials – March 17, 2025
The company has announced the authorization of its Clinical Trial Application (CTA) from the regulatory authorities in four European countries under the European Union’s (EU) harmonised framework, for VIDAR-1, with Germany acting as the reference state.
Clinical Trials – February 28, 2025
Evaxion Biotech will further enhance the data package from its ongoing phase 2 trial with the company’s lead asset EVX-01 by extending the trial from two to three years.
Financing – May 7, 2025
The company has raised financing through a private placement led by Sandberg Development.
Pharma Business – May 5, 2025
Cantargia has announced the selection of a subgroup of atopic dermatitis (AD) patients, not responding to first line dupilumab treatment, as its second target indication for CAN10.
Business article – May 2, 2025
In January 2025, the Aurevia brand was established when Labquality, Artimed, Clinical Consulting, Kasve, and Prisma CRO merged under the same name. Now, Scandinavian CRO (SCRO) and QAdvis will also operate under the name of Aurevia.
Business Award – April 29, 2025
The new award, Pioneer Prize, launched by the Swedish Institute and Business Sweden, aims to highlight the best in Swedish innovation.
Finland – April 23, 2025
Euro-BioImaging Finland, the research infrastructure of Finnish bioimaging, has received funding of about EUR 28 million from the Research Council of Finland.
Acquisition – April 22, 2025
RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, has announced a recommended public tender offer to the shareholders of Biotage to transfer all of the ordinary shares of Biotage to RWK BidCo for SEK 145 in cash per ordinary share.
Biotech Business – May 7, 2025
The company has announced a new collaboration focused on developing antibody-based therapies for acute and critical care of cardiovascular disease.
Biotech Business – April 29, 2025
The acceleration program is organized by the Swedish-American Chamber of Commerce in New York (SACCNY) in collaboration with EY.
Biotech Business – April 28, 2025
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for market authorization of Oczyesa, octreotide subcutaneous depot, for the maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.
COVID-19 – May 2, 2025
The discovery, made by researchers at Karolinska Institutet, can pave the way for future diagnosis and treatment.
Science article – April 25, 2025
In 2023, there were an estimated 263 million malaria cases, and 597,000 malaria deaths, making it a prioritized field for many researchers around the world. In Umeå, Sweden, Professor Oliver Billker’s group is focusing on the basic biology of the parasite, with the goal to develop new drugs and vaccines and understand why some mosquito species transmit malaria while others do not.
Science News – April 9, 2025
A simpler method of analyzing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund University.
Stryker
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better.
Stryker
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better.
Stryker
In this role, you will drive product strategy, including robotics and software solutions, collaborate with cross-functional teams, and help modernize our marketing and sales approach through digital and omnichannel initiatives.
Ascendis Pharma
Ascendis Pharma A/S, a U.S. publicly held, Biopharmaceutical company founded in Copenhagen, Denmark in 2007, committed to addressing unmet medical needs within the therapeutic area’s endocrinology and oncology.
Argon Medical Devices
ARGON Medical Devices is a global manufacturer of specialty medical products, headquartered in Plano, Texas. The company offers a broad range of medical devices for Interventional Radiology, Vascular Surgery, Interventional Cardiology and Oncology.
Bioneer
Bioneer is a trusted strategic partner for Biotech and Pharmaceutical companies worldwide. With 40 years of experience, they drive impact in the Life Science ecosystem across the Nordics and globally as a Danish government-approved Research and Technology Organization (RTO).
In a new job – May 5, 2025
The tenure of Kari Stefánsson, founder and CEO of deCODE genetics, has come to an end and the company has appointed two co-managing directors during the transition.
In a new job – April 24, 2025
Hansa Biopharma has announced the appointment of Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately.
Biotech Business – April 15, 2025
Nykode announces that Michael Engsig, CEO, Agnete Fredriksen, CSO & Co-founder, and Harald Gurvin, CFO, have withdrawn their recent resignations and will continue with Nykode.
Business Award – April 24, 2025
Leon Wyszkowski, president of analytical services for clinical research, has received the Key to Gothenburg, on behalf of Thermo Fisher during a ceremony at the City Hall.
Career choice – April 10, 2025
Hamid Parsa has always wanted to do something that adds value to society and people, and within life sciences he has the opportunity to do just that.
Career choice – March 14, 2025
Charlotte Schönbeck has always been inquisitive and as sales specialist she gets to work with many different life science professionals. She learns something new from all of them by working together through their individual challenges to find the best solution.
Profiles in Pharma – April 2, 2025
For Sirpa and Markku Jalkanen of Finland, M.D. and Ph.D., married, immunotherapy researchers, working together came as naturally as a courtship.
Nobel Prize Laureate – December 12, 2024
Victor Ambros, Professor of Molecular Medicine and the Silverman Chair in Natural Sciences at the University of Massachusetts Chan Medical School, is one of this year’s winners of the Nobel Prize in Physiology or Medicine.
Nobel Prize Laureate – December 10, 2024
More than three decades after their discovery of microRNA, Professor Gary Ruvkun received the “mythic call” from Stockholm to learn that he’d been awarded the Nobel Prize in Physiology or Medicine alongside his erstwhile colleague Victor Ambros.
This site uses cookies
